Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

ClinicalTrials.gov ID: NCT04429503

Public ClinicalTrials.gov record NCT04429503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 11:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Masked, Active-Controlled Phase 2/3 Study of the Efficacy and Safety of High-Dose Aflibercept in Patients With Diabetic Macular Edema

Study identification

NCT ID
NCT04429503
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
660 participants

Conditions and interventions

Interventions

  • High-dose aflibercept Drug
  • aflibercept Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 28, 2020
Primary completion
May 29, 2022
Completion
Jun 17, 2024
Last update posted
Aug 7, 2025

2020 – 2024

United States locations

U.S. sites
84
U.S. states
29
U.S. cities
81
Facility City State ZIP Site status
Regeneron Study Site Phoenix Arizona 85021
Regeneron Study Site Arcadia California 91006
Regeneron Study Site Beverly Hills California 90211
Regeneron Study Site Campbell California 95008
Regeneron Study Site Encino California 91436
Regeneron Study Site Fullerton California 92835
Regeneron Study Site Huntington Beach California 92647
Regeneron Study Site Long Beach California 90807
Regeneron Study Site Palo Alto California 94303
Regeneron Study Site Pasadena California 91107
Regeneron Study Site Poway California 92064
Regeneron Study Site Rancho Cordova California 95670
Regeneron Study Site Riverside California 92505
Regeneron Study Site Torrance California 90509
Regeneron Study Site Colorado Springs Colorado 80909
Regeneron Study Site Durango Colorado 81301
Regeneron Study Site Lakewood Colorado 80228
Regeneron Study Site Waterford Connecticut 06385
Regeneron Study Site Clearwater Florida 33761
Regeneron Study Site Fort Lauderdale Florida 33308
Regeneron Study Site Fort Myers Florida 33912
Regeneron Study Site Jacksonville Florida 32216
Regeneron Study Site Lakeland Florida 33805
Regeneron Study Site Largo Florida 33770
Regeneron Study Site Melbourne Florida 32901
Regeneron Study Site Miami Florida 33126
Regeneron Study Site Orlando Florida 32806
Regeneron Study Site Pinellas Park Florida 33782
Regeneron Study Site Plantation Florida 33324
Regeneron Study Site St. Petersburg Florida 33711
Regeneron Study Site Stuart Florida 34994
Regeneron Study Site Winter Haven Florida 33880
Regeneron Study Site Augusta Georgia 30909
Regeneron Study Site 1 Marietta Georgia 30060
Regeneron Study Site 2 Marietta Georgia 30060
Regeneron Study Site ‘Aiea Hawaii 96701
Regeneron Study Site Oak Forest Illinois 60452
Regeneron Study Site Springfield Illinois 62703
Regeneron Study Site Springfield Illinois 62704
Regeneron Study Site Carmel Indiana 46290
Regeneron Study Site Shawnee Mission Kansas 66204
Regeneron Study Site Baltimore Maryland 21209
Regeneron Study Site Hagerstown Maryland 21740
Regeneron Study Site Boston Massachusetts 02114
Regeneron Study Site Royal Oak Michigan 48073
Regeneron Study Site Southaven Mississippi 38671
Regeneron Study Site Henderson Nevada 89052
Regeneron Study Site Bloomfield New Jersey 07003
Regeneron Study Site Edison New Jersey 08820
Regeneron Study Site Teaneck New Jersey 07666
Regeneron Study Site Great Neck New York 11021
Regeneron Study Site Liverpool New York 13088
Regeneron Study Site New York New York 11221
Regeneron Study Site Oceanside New York 11572
Regeneron Study Site Shirley New York 02114
Regeneron Study Site Asheville North Carolina 28803
Regeneron Study Site Charlotte North Carolina 28210
Regeneron Study Site Beachwood Ohio 44122
Regeneron Study Site Cincinnati Ohio 45202
Regeneron Study Site Cincinnati Ohio 45242
Regeneron Study Site Cleveland Ohio 44130
Regeneron Study Site Dublin Ohio 43016
Regeneron Study Site Edmond Oklahoma 73013
Regeneron Study Site Tulsa Oklahoma 74114
Regeneron Study Site Portland Oregon 97225
Regeneron Study Site Bethlehem Pennsylvania 18017
Regeneron Study Site Kingston Pennsylvania 18704
Regeneron Study Site Monroeville Pennsylvania 15146
Regeneron Study Site Beaufort South Carolina 29902
Regeneron Study Site Ladson South Carolina 29456
Regeneron Study Site West Columbia South Carolina 29169
Regeneron Study Site Rapid City South Dakota 57701
Regeneron Study Site Germantown Tennessee 38138
Regeneron Study Site Knoxville Tennessee 37922
Regeneron Study Site Nashville Tennessee 37203
Regeneron Study Site Abilene Texas 79606
Regeneron Study Site Bellaire Texas 77401
Regeneron Study Site 2 San Antonio Texas 78240
Regeneron Study Site The Woodlands Texas 77384
Regeneron Study Site Willow Park Texas 76087
Regeneron Study Site 1 Salt Lake City Utah 84107
Regeneron Study Site Fairfax Virginia 22031
Regeneron Study Site Norfolk Virginia 23502
Regeneron Study Site Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04429503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 7, 2025 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04429503 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →